Retracted: Promoting the Recovery of Injured Liver with Poly (3-Hydroxybutyrate-Co-3-Hydroxyvalerate-Co-3-Hydroxyhexanoate) Scaffolds Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells

Abstract

The article entitled, Promoting the Recovery of Injured Liver with Poly (3-Hydroxybutyrate-Co-3-Hydroxyvalerate-Co-3-Hydroxyhexanoate) Scaffolds Loaded with Umbilical Cord-Derived Mesenchymal Stem Cells by Li P, Zhang J, Liu J, Ma H, Liu J, Lie P, Wang Y, Liu G, Zeng H, Li Z, and Wei X (Tissue Eng. 2015;21(3–4):603–615. DOI: 10.1089/ten.tea.2013.0331) is being retracted due to the potential evidence of image manipulation. This retraction is in connection with another article¹ that was retracted due to evidence of scientific misconduct.²

The Editors of Tissue Engineering are committed to preserving the integrity of the scientific literature and the community it serves.

References

1. Wu A, Fan L, Xu B, Lin Y, Zhang P, and Wei X. Use of decellularized scaffolds combined with hyaluronic acid and basic fibroblast growth factor for skin tissue engineering. Tissue Eng 2015;21(1–2):390–402. DOI: 10.1089/ten.tea.2013.0260.

2. Retraction of: Use of Decellularized Scaffolds Combined with Hyaluronic Acid and Basic Fibroblast Growth Factor for Skin Tissue Engineering by Wu A, Fan L, Xu B, Lin Y, Zhang P, and Wei X. Tissue Eng 2015;21(1–2):390–402. DOI: 10.1089/ten.tea.2013.0260. Epub: 19 Mar 2020 https://doi.org/10.1089/ten.tea.2013.0260.retract.

Introduction

As one of the most important organs in the human body, the liver has important functions in metabolism, and the endocrine and exocrine systems. Various liver diseases, such as acute liver failure, hepatitis B cirrhosis, primary billary cirrhosis, metabolic liver disease, alcoholic liver disease, and hepatocellular carcinoma, seriously threaten human health around the world due to high morbidity and mortality. There are big demands to develop effective therapies to treat these diseases. Clinically, liver transplantation is still the major method for the treatment of some serious late-stage liver diseases.¹ But, it is limited by the shortage of donor organs, high costs, and the long-term use of immunosuppressive drugs. New cell-based therapies of liver diseases became the focus of research to create an artificial liver as a substitute for donor organs.²

Three-dimensional biocompatible scaffolds can provide a supporting structure for cell growth, facilitate the cell–cell and cell–matrix interactions, and have a promoting effect on cell attachment and differentiation.^3,4 Finding a suitable scaffold plays an important role in tissue engineering. Polyhydroxyalkanoate (PHA) is a family of polyesters produced by bacteria under unbalanced growth conditions.⁵ Poly(3-hydroxybutyrate) (PHB) is a homopolymer and a member of PHA family and was extensively studied for tissue engineering.^6,7 However, PHB is a high crystallinity polymer and highly brittle, which limits its use in tissue engineering.⁸ poly(3-hydroxybutyrate-co-4-hydroxybutyrate) (P3HB4HB) and poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHx) are also members of PHA family and copolymers consisting of short-chain-length PHAs (scl-PHAs) and medium-chain-length PHAs (mcl-PHAs). Copolymerization of scl-PHAs and mcl-PHAs was showed to have better biodegradability and improved physical properties compared with homopolymer PHB.⁹ As a new member of PHA family, poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) was produced by recombinant Aeromonas hydrophila 4AK4.¹⁰ PHBVHHx had better biocompatibility than other PHAs, such as PHB, P3HB4HB, and PHBHHx¹¹ and is a promising biomaterial for the growth of stem cells.

In addition to the selection of biomaterials, the choice of seeding cells is another major factor in the determination of outcome of tissue engineering. Mesenchymal stem cells (MSCs) proved to be attractive seeding cells for tissue engineering. They can be easily obtained from many different tissues, including bone marrow, adipose tissue, umbilical cord, and umbilical cord blood.^12,13 They can be cultured for many passages in vitro as undifferentiated cells and provide a large number of cells required for tissue engineering. They are multipotent cells and can differentiate into many different cells under suitable conditions, including osteoblasts, chondrocytes, adipocytes, endothelial cells, and neurons.^13,14 MSCs were widely tested for tissue engineering in vitro, in animals and clinical trials.^15,16 They were recently isolated from human umbilical cord Wharton's jelly (WJ-MSCs).¹⁷ WJ-MSCs are more primitive than those isolated from other tissues.¹⁸ Previous studies showed that WJ-MSCs were less immunogenic and were still viable and not rejected 4 months after transplantation as xenografts without the need of use of immunosuppressive drugs.¹⁹ In addition, umbilical cord can be easily obtained and provides a noncontroversial source of MSCs. Therefore, WJ-MSCs represent a promising cell source for tissue engineering.

In this study, PHBVHHx was used as biomaterial for preparation of three-dimensional supportive scaffolds and WJ-MSCs were used as seeding cells for hepatic tissue engineering. PHBVHHx scaffolds loaded with WJ-MSCs were transplanted into liver-injured mice. Effects of WJ-MSCs on the recovery of chronic liver damage were evaluated.

Materials and Methods

Establishment of hepatic injury animal model

All procedures involving experimental animals were conducted in accordance with the institutional guideline and approved by the Animal Care Committee of the Jinan University. KM mice (6–8 week old) were purchased from Experimental Animal Center of Shantou University. To induce chronic liver damage, 20% carbon tetrachloride (CCl₄; Guangzhou Chemical Reagent Factory) dissolved in vegetable oil was intraperitoneally injected to the female mice at a dose of 2.0 mL/kg body weight every 3 days. The same amount of vegetable oil was injected as a negative control. Mice were sacrificed after 14 and 30 days of the first injection of CCl₄. Serum samples were collected for biochemical analysis. Liver was removed, and liver sections were cut for hematoxylin-eosin (HE) staining (Beyotime) and Masson staining (Naniingjiancheng).

Preparation of PHBVHHx

PHBVHHx was produced by recombinant Aeromonas hydrophila 4AK4 harboring phaAB genes. The recombinant strain was cultured as previously described at 30°C for 60 h in 500 mL conical flasks containing 100 mL mineral medium in a rotary shaker (Fuma) at 200 rpm.²⁰ Mineral medium was supplemented with dodecanoic acid and propionic acid as carbon sources. P (3HB-co-3 mol% 3HV-co-12 mol% 3HHx) was produced by the recombinant strain and used in this study.

Preparation of films and scaffolds and scanning electron microscopy

Poly(L-lactic acid) (PLA) (120 kDa; NatureWorks), P3HB4HB (590 kDa; Tian Green), PHBHHx (440 kDa; Lukang), and PHBVHHx were used for the preparation of films and scaffolds. Films were prepared by solvent-casting method using 2% polymers in chloroform (YongDa Reagent Development Center). After being refluxed at 60°C for 30 min, polymer solution was poured into a glass dish (18 mm in diameter) to allow solvent evaporation in air at room temperature. Films were further dried in vacuum for 48 h.

Polymer scaffolds were fabricated using solid–liquid phase separation method as previously described.²¹ Briefly, polymers were dissolved in 1,4-dioxane at concentrations of 2%, 3%, 4%, and 5% (Tianjin Damao Chemical Reagent Factory). After being refluxed at 65°C for 2 h to form a homogeneous solution, the polymer solution was poured into a glass mold. The mold was placed in −80°C for 48 h and vacuum-lyophilized for 3–5 days to form scaffolds. Scaffolds were examined by scanning electron microscopy (SEM) as previously described.²⁰

Isolation and culture of WJ-MSCs

Human umbilical cord was aseptically acquired from full-term cesarean section patients at the First Affiliated Hospital of Jinan University after informed consent and approval from the local Ethical Review Board at Jinan University. Wharton's jelly was cut into small pieces of about 1.5–2.5 mm. They were placed in a six-well plate (Corning) and cultured in the growth medium containing Dulbecco's modified Eagle's medium-low glucose (DMEM-LG; Invitrogen) supplemented with 10% fetal bovine serum (FBS; Sijiqing), 5 ng/mL basic fibroblast growth factor (PeproTech), 1% penicillin-streptomycin, and 1 μg/mL amphotericin B (Invitrogen) in a 37°C incubator containing 5% CO₂. Cells were cultured without disturbance for 10–15 days. During cell culture, cells migrated out from the small pieces of Wharton's jelly. Cells were harvested by 0.25% trypsin digestion and passaged for cell expansion. Medium was changed every 3 days.

Determination of cell attachment and viability

Cell attachment and viability were analyzed by Cell Counting Kit-8 assay (CCK-8; Dojindo) as previously described.²² For CCK-8 assay, substrate WST-8 is reduced by dehydrogenases in mitochondria of living cells to give a soluble yellow-colored product (formazan). The amount of the formazan dye generated by the activity of dehydrogenases in cells is directly proportional to the number of viable cells.⁹ CCK-8 is similar to a methylthiazol tetrazolium (MTT) assay. Both of them have similar principles and can determine cell attachment and viability. But, CCK-8 assay is more sensitive and accurate and faster than MTT. In MTT assay, succinate dehydrogenase in mitochondria of living cells can reduce substrate MTT into insoluble crystal violet formazan.²³ For CCK-8 assay in this study, 2×10⁴ WJ-MSCs were added to each film or scaffold in 24-well plate. After 4 and 72 h culture, the medium was aspirated and 450 μL serum-free medium and 50 μL CCK-8 solution were added to each sample. After 2 h incubation at 37°C, the optical density was measured at 450 nm using a 96-well spectrophotometer (MK3; Thermo).

Labeling WJ-MSCs with a fluorescent dye

WJ-MSCs were labeled with fluorescent dye as previously described.²⁴ WJ-MSCs were incubated at 37°C for 5 min, 4°C for 15 min with 4 μM lipophilic fluorochrome chloromethylbenzamido dialkylcarbocyanine (CM-DiI; Molecular Probes).

Seeding WJ-MSCs into PHBVHHx scaffolds

Seeding WJ-MSCs into PHBVHHx scaffolds was performed as previously described.²⁵ Sterilized PHBVHHx scaffolds were placed in 24-well cell culture plates (Corning). A total of 2×10⁶ WJ-MSCs labeled with CM-DiI fluorescent dye in 50 μL culture medium were added to each scaffold. After incubation at 37°C for 30 min, DMEM-LG (Invitrogen) supplemented with 10% FBS was added to each well.

Scaffold implantation into liver-injured mice

After mice were injected with CCl₄ for 30 days to cause liver injury, mice were divided into three groups: (1) they did not receive transplantation (CCl₄); (2) They received the transplantation of PHBVHHx scaffolds loaded with cell-free culture medium (Scaffold); (3) They received the transplantation of PHBVHHx scaffolds loaded with labeled WJ-MSCs (WJ-MSCs+scaffold). The surgical procedure was performed as previously described.²⁶ Animals were anesthetized with 5% chloral hydrate (0.08 mL/10 g) (Tianjinguangfu) by intraperitoneal injection and then fixed supinely. The surgical area was disinfected with iodophor. A midline abdominal incision (2–3 cm) was made and PHBVHHx scaffolds were placed within the omentum. The abdominal incision was closed in two layers with 4-0 absorbable suture (Shanghaitianqing). Each mouse was kept separately in each cage and checked everyday for health condition.

Liver functional assays of animal serum

A total of 200–500 μL blood was collected from mice by heart puncture on day 14 and 30 after CCl₄ injection to cause liver injury and on day 14 and 30 after scaffold transplantation into liver-injured mice. Blood was collected from normal mice as controls. Concentrations of serum alanine aminotransferase (ALT), total bilirubin (TB), and albumin (ALB) were measured according to the manufacturer's instruction (Nanjinjiancheng).

HE staining and Masson staining

Mouse liver and scaffolds loaded with WJ-MSCs before and after transplantation were embedded in Optimum Cutting Temperature Compound (Sakura). The 10 μm sections were cut and stained with HE staining (Beyotime) according to the manufacturer's instructions. The livers were fixed in 10% neutral formalin solution for more than 24 h and embedded in paraffin. The tissue was sectioned at 4 μm and subsequently stained with Masson staining (Nanjingjiancheng) according to the manufacturer's instructions.

Real-time reverse transcription–polymerase chain reaction

Real-time reverse transcription–polymerase chain reaction (real-time RT-PCR) was performed and the data analyzed as previously described.²⁷ Shortly, total RNA was extracted from livers and scaffolds loaded with WJ-MSCs using Total RNA Kit I (Omega) following the manufacturer's instructions and digested with RNases-free DNase (Promega). cDNA synthesis was preformed with 2 μg total RNA using Reverse transcriptase M-MLV (TaKaRa). Real-time RT-PCR was performed in 25 μL reaction volume containing 12.5 μL GoTaq^® qPCR Master Mix (Promega), 1 μL of each primer and 2 μL cDNA. After denaturing for 10 min at 95°C, PCR amplification was performed for 40 cycles of 15 s at 95°C, 1 min at 56°C, and 1 min at 72°C using the Bio-Rad Real-Time PCR system (Bio-Rad). The mRNA expression levels were normalized with GAPDH. The PCR primers were listed in Table 1.

Table 1.

List of Polymerase Chain Reaction Primer Sequences for Real-Time Reverse Transcription–Polymerase Chain Reaction

Genes		Primer sequences (5′-3′)
ALB (human)	Forward	GCCTGCTGACTTGCCTTCATTAG
	Reverse	TCAGCAGCAGCACGACAGAGTA
AFP (human)	Forward	GAAACCCACTGGAGATGAACAGTC
	Reverse	AAGTGGGATCGATGCAGGA
CK-18 (human)	Forward	GATCGACCTGGACTCCATGAGAA
	Reverse	CCGTTGAGCTGCTCCATCTGTA
Flk-1 (human)	Forward	GACTTCCTGACCTTGGAGCATCT
	Reverse	GATTTTAACCACGTTCTTCTCCGA
vWF (human)	Forward	CAAGGAAGAAAATAACACAGGTGAA
	Reverse	TCATTGACCTTGCAGAAGTGAGTAT
VE-cadherin (human)	Forward	CAACTTTACCCTCACGGATAATCAC
	Reverse	ACTTGGCATCCCATTGTCTGAG
GAPDH (human)	Forward	CGGAGTCAACGGATTTGGTCGTAT
	Reverse	AGCCTTCTCCATGGTGGT
Flk-1 (mouse)	Forward	ATTATCCTCGTCGGCACT
	Reverse	TCATAAGGCAAGCGTTCA
vWF (mouse)	Forward	TACCACGAGGTCATCAACG
	Reverse	GGATAGCCAGGTCATAGCAT
VE-cadherin (mouse)	Forward	CGCCAACATCACGGTCAA
	Reverse	CGGTTAGCGTGCTGGTTC
CK-19 (mouse)	Forward	GTGTCCTCCACCCGCTTCGT
	Reverse	TCGCCATTGGCCTGCTCT
GAPDH (mouse)	Forward	GTTGTCTCCTGCGACTTCA
	Reverse	GGTGGTCCAGGGTTTCTTA

Immunocytochemistry

After transplantation for 14 and 30 days, cells were harvested with trypsin from scaffolds loaded with WJ-MSCs and cultured overnight at 1×10⁴ cells/cm² in growth medium in a 24-well plate (Corning). Immunocytochemistry was performed as previously described.²⁸ Cells were incubated for 1 h with mouse monoclonal antibody against human α-fetoprotein (AFP), ALB, and cytokeratin 18 (CK-18) (1:50; Santa Cruz Biotechnology). Cells were incubated for 1 h with phycoerythrin-conjugated goat anti-mouse immunoglobulin G (1:100; Santa Cruz Biotechnology). Cell nuclei were stained for 5 min with diamidinophenylindole (Beyotime).

Periodic acid–Schiff staining for glycogen storage

After transplantation for 14 and 30 days, cells were harvested with trypsin from scaffolds loaded with WJ-MSCs and cultured overnight at 1×10⁴ cells/cm² in growth medium in a 24-well plate (Corning). Periodic acid–Schiff staining was performed as previously described.²⁹ Cells were incubated with periodic acid solution (Sigma) for 5 min and immersed in Schiff's reagent (Sigma) for 15 min. Cells were counterstained in hematoxylin solution (Sigma) for 90 s.

Statistical analysis

Data are expressed as mean±standard error of the mean. Statistical comparisons were performed using the Student's t-test. p-Values <0.05 were considered statistically significant.

Results

Characterization of polymer scaffolds by SEM

The microstructures of different polymer scaffolds were examined by SEM. All of the scaffolds were prepared by the same solid–liquid phase separation method. The scaffolds were cut into 12 mm in diameter and 5 mm in thickness. Scaffolds were prepared with PHBVHHx and the commonly used polymers PLA, P3HB4HB, and PHBHHx and displayed the different pore sizes (Fig. 1A). P3HB4HB scaffolds contained the largest pores among all the scaffolds examined. PHBHHx and PHBVHHx scaffolds possessed the smaller and more uniform pore sizes.

FIG. 1.

Examination of mesenchymal stem cells from human umbilical cord Wharton's jelly (WJ-MSCs) loaded into polymer scaffolds. (A) Scaffolds were prepared from different polymers and examined by scanning electron microscopy. Different polymer scaffolds displayed the different pore sizes. (B) Analysis of attachment of WJ-MSCs loaded into polymer scaffolds. The different polymer scaffolds were prepared at concentrations of 2%, 3%, 4%, and 5%, and the different films at 2%. Cell attachment on the different films and scaffolds was studied using Cell Counting Kit-8 (CCK-8) assay after WJ-MSCs were incubated for 4 h. Poly (3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) (PHBVHHx) scaffolds exhibited the highest cell attachment compared with the other commonly used polymers (n=6). *p<0.01 versus respective film. (C) Analysis of viability of WJ-MSCs loaded into polymer scaffolds. Cell viability on the different films and scaffolds was studied using CCK-8 assay after WJ-MSCs were incubated for 72 h. PHBVHHx scaffolds showed much higher cell viability than the other commonly used polymers (n=6). *p<0.01 versus respective film.

Analysis of attachment and viability of WJ-MSCs inside polymer scaffolds

The different scaffolds were prepared at concentrations of 2%, 3%, 4%, and 5%, and the different films at 2%. Cell attachment on the different films and scaffolds was studied using CCK-8 assay after WJ-MSCs were incubated for 4 h in the growth medium. PHBVHHx scaffolds exhibited the highest cell attachment compared with the commonly used polymers PLA, P3HB4HB, and PHBHHx (Fig. 1B). Different scaffolds had significantly higher cell attachment than their respective films. In addition, the same polymer scaffold prepared at different concentrations showed similar results.

Cell viability on different films and scaffolds was studied using CCK-8 assay after WJ-MSCs were incubated for 72 h in the growth medium. PHBVHHx scaffolds showed much higher cell viability than the commonly used polymers PLA, P3HB4HB, and PHBHHx (Fig. 1C). In agreement with cell attachment results, different scaffolds had significantly higher cell attachment than their respective films, and the same polymer scaffold prepared at different concentrations showed similar results.

Characterization of liver-injured mouse model

In this study, 20% CCl₄ was injected into mice every 3 days for 30 days to induce chronic liver damage. The difference of livers from normal and liver-injured mice is very obvious (Fig. 2A). The surface of normal liver looked normal and smooth. In contrast, liver from liver-injured mice was swelling, and the surface was pale and rough and showed many small nodules.

FIG. 2.

Characterization of hepatic injury mouse model. (A) 20% carbon tetrachloride (CCl₄) was injected into mice every 3 days for 30 days to induce chronic liver damage. Microscopic pictures were taken from livers of normal mice (Control) and liver-injured mice (CCl₄). The difference of livers from normal and liver-injured mice is very obvious. (B) Blood samples were collected from normal and liver-injured mice. Concentrations of serum alanine aminotransferase (ALT), total bilirubin (TB), and albumin (ALB) were measured. The results showed that ALT and TB were significantly higher, and ALB was significantly lower after 14 and 30 days of CCl₄ injection. *p<0.01 versus respective normal mice control. (C) Livers were removed from normal and injured mice after 14 and 30 days of CCl₄ injection. Liver tissue sections were examined after hematoxylin-eosin (HE) and Masson staining. Liver damage was observed and liver showed blue by Masson staining for collagen deposition after CCl₄ injection. Color images available online at www.liebertpub.com/tea

Blood samples were collected from normal and liver-injured mice and centrifuged to get serum. Concentrations of serum ALT, TB, and ALB were measured. The results showed that ALT and TB were significantly higher, and ALB was significantly lower in mice after 14 and 30 days of CCl₄ injection (Fig. 2B).

Livers were removed from normal and injured mice, and liver tissue sections were examined after HE and Masson staining. HE staining showed that the control mice liver had normal structure of liver lobules and normal size and shape of hepatic cells. In contrast, the injured liver after 14 and 30 days of CCl₄ injection had obvious pathological changes, including hepatocellular degeneration, necrosis, vacuolization, and inflammatory infiltration (Fig. 2C). Masson staining demonstrated that injured liver after 14 and 30 days of CCl₄ injection had the obvious blue staining for collagen deposition compared with the normal liver (Fig. 2C). In addition, injured liver after 30 days of CCl₄ injection showed bluer staining than after 14 days of CCl₄ injection.

Transplantation of PHBVHHx scaffolds into liver-injured mice

After mice were injected with CCl₄ for 30 days to cause liver injury, they did not receive transplantation (CCl₄ group) or received transplantation of PHBVHHx scaffolds loaded with cell-free culture medium (Scaffold group) or received transplantation of PHBVHHx scaffolds loaded with WJ-MSCs (WJ-MSCs+scaffold group). Normal mice were used as controls (Control group). Livers were removed after 14 and 30 days of transplantation. Liver morphology on day 30 in the WJ-MSCs+scaffold group significantly improved, and it looked similar to the normal liver (Fig. 3A).

FIG. 3.

Transplantation of PHBVHHx scaffolds into liver-injured mice. (A) After mice were injected with CCl₄ for 30 days to cause liver injury, they did not receive transplantation (CCl₄) or received the transplantation of PHBVHHx scaffolds loaded with cell-free culture medium (Scaffold) or received the transplantation of PHBVHHx scaffolds loaded with WJ-MSCs (WJ-MSCs+scaffold). Liver after 30 days of transplantation of PHBVHHx scaffolds loaded with WJ-MSCs significantly improved compared with all other livers, and it looked similar to the normal liver. (B) Blood was collected from mice after 14 and 30 days of transplantation. Normal mice were used as controls (Control). Concentrations of ALT and TB were significantly lower, and ALB was significantly higher in the WJ-MSCs+scaffold group than in the CCl₄ group. *p<0.01 versus respective normal mice control; ^#p<0.01 versus respective CCl₄ mice. Color images available online at www.liebertpub.com/tea

Blood was collected from liver-injured mice or from normal mice. Concentrations of serum ALT and TB were significantly lower, and ALB was significantly higher on days 14 and 30 in the WJ-MSCs+scaffold group than in the CCl₄ group (Fig. 3B). In addition, concentrations of ALT, TB, and ALB changed more in animals on day 30 post-transplantation of WJ-MSCs+scaffold than on day 14.

Mouse livers were removed after 14 and 30 days of transplantation, and liver tissue sections were examined after HE and Masson staining. HE staining showed that on day 30 in the WJ-MSCs+scaffold group, liver had similar structure of normal liver lobules, liver acini similar to these of normal liver, and similar size and shape of normal hepatic cells, and there were significantly less hepatic cell degeneration, necrosis, vacuolization, and inflammatory infiltration in the liver compared with all the other livers (Fig. 4A). Masson staining demonstrated that liver on day 30 in the WJ-MSCs+scaffold group had significantly less blue staining for collagen deposition compared with all the other livers (Fig. 4A).

FIG. 4.

The scaffolds promote the reconstruction of healthy mouse liver structures. (A) Mouse liver tissue sections were examined after HE and Masson staining. Liver tissues improved and were significantly less blue by Masson staining for collagen deposition after 30 days of transplantation of PHBVHHx scaffolds loaded with WJ-MSCs. (B) The expression of bile duct epithelial cell gene CK-19 in mouse liver was examined by real-time reverse transcription–polymerase chain reaction (RT-PCR). CK-19 expression in mouse liver is significantly lower on days 14 and 30 in the WJ-MSCs+scaffold group than in the other groups (n=5). *p<0.01 versus respective normal mice control; ^#p<0.01 versus respective CCl₄ mice. (C) The expression of the endothelial cell genes Flk-1, vWF, and VE-cadherin was analyzed by real-time RT-PCR. The expression of these genes in mouse liver did not significantly change on days 14 and 30 after WJ-MSCs in scaffolds were transplanted into liver-injured mice (n=5). Color images available online at www.liebertpub.com/tea

Real-time RT-PCR showed that the expression of the bile duct epithelial cell gene CK-19 was detected at a low level in normal mouse liver (Control) and significantly increased on day 30 after CCl₄ injection (Fig. 4B). CK-19 expression was significantly lower in mouse liver on days 14 and 30 in the WJ-MSCs+scaffold group than in the CCl₄ group (Fig. 4B). Real-time RT-PCR demonstrated that the expression of the endothelial cell genes Flk-1, vWF, and VE-cadherin in mouse liver did not significantly change on days 14 and 30 in the WJ-MSCs+scaffold group compared with the other groups (Fig. 4C), indicating that WJ-MSC transplantation did not significantly change vascularization.

Cell repopulation in the scaffolds after transplantation

Cell repopulation in the scaffolds after transplantation was investigated. Real-time RT-PCR and immunocytochemistry showed that cells expressed hepatocyte genes ALB, AFP, and CK-18 on days 14 and 30 in the WJ-MSCs+scaffold group, indicating that WJ-MSCs in scaffolds differentiated into hepatocyte-like cells (Fig. 5A, B). Cells expressed the transcripts of these three genes at a higher level on day 30 following transplantation compared with that on day 14 (Fig. 5A). Periodic acid–Schiff staining also demonstrated that WJ-MSCs differentiated into hepatocyte-like cells on days 14 and 30 in the WJ-MSCs+scaffold group (Fig. 5C). Real-time RT-PCR demonstrated that WJ-MSCs in scaffolds expressed endothelial cell genes Flk-1, vWF, and VE-cadherin on days 14 and 30 in the WJ-MSCs+scaffold group, indicating that WJ-MSCs also differentiated into endothelial-like cells (Fig. 5D).

FIG. 5.

Investigation of the cell repopulation in the scaffolds after transplantation. (A) The expression of hepatocyte genes ALB, α-fetoprotein (AFP), and cytokeratin 18 (CK-18) was analyzed by real time RT-PCR. Cells expressed these genes at a higher level on days 14 and 30 after WJ-MSCs in scaffolds were transplanted into liver-injured mice compared with no transplantation control (n=5). *p<0.05 relative to respective control. (B) The expression of ALB, AFP, and CK-18 was also analyzed by immunocytochemistry. Cells expressed ALB, AFP, and CK-18 on days 14 and 30 after WJ-MSCs in scaffolds were transplanted into liver-injured mice. (C) The differentiation of WJ-MSCs into hepatocyte-like cells was examined by periodic acid–Schiff staining. WJ-MSCs differentiated into hepatocyte-like cells on days 14 and 30 post-transplantation. (D) The differentiation of WJ-MSCs into endothelial-like cells was examined by real-time RT-PCR. Cells expressed endothelial cell genes Flk-1, vWF, and VE-cadherin on days 14 and 30 after WJ-MSCs in scaffolds were transplanted into liver-injured mice (n=5). *p<0.01 relative to respective control. Color images available online at www.liebertpub.com/tea

Cell tracing after transplantation

To trace WJ-MSCs after their transplantation, they were labeled with fluorescent dye CM-DiI before transplantation. PHBVHHx scaffolds loaded with the labeled cells were transplanted into liver-injured mice after 30 days of CCl₄ injection. Scaffolds were removed after 14 and 30 days of transplantation. Scaffold sections were observed under a fluorescence microscope. Fluorescent cells in scaffolds were observed before and after transplantation and decreased after 30 days of transplantation compared with 14 days (Fig. 6A). Scaffold sections were also examined after HE staining. Stained cells in scaffolds were observed after 14 and 30 days of transplantation of scaffolds loaded with WJ-MSCs, and no stained cells in scaffolds were observed after 14 and 30 days of transplantation of scaffolds loaded with cell-free culture medium (Fig. 6B).

FIG. 6.

Cell tracing after transplantation. (A) To trace WJ-MSCs after their transplantation, they were labeled with chloromethylbenzamido dialkylcarbocyanine before transplantation. Labeled cells loaded into PHBVHHx scaffolds were transplanted into liver-injured mice after 30 days of CCl₄ injection. Scaffolds were removed after 14 and 30 days of transplantation. Fluorescent cells in scaffolds were observed before and after transplantation. (B) Scaffold sections were also examined by HE staining. Stained cells in scaffolds were observed after 14 and 30 days of transplantation of scaffolds loaded with WJ-MSCs. Color images available online at www.liebertpub.com/tea

Discussion

The advent of tissue engineering provides new ways for the treatment of liver injury. Combination of suitable seeding cells and ideal biomaterials may simulate different organs and solve the serious shortage of donor organs. WJ-MSCs is one type of adult stem cells that have multipotent differentiation potential and can differentiate into many other types of cells including hepatocyte-like cells under suitable induction conditions in vitro and in vivo.^30,31 WJ-MSCs have low immunogenicity and can reduce the immune rejection after their transplantation.³² In this study, WJ-MSCs were isolated from umbilical cord Wharton's jelly. Flow cytometry analysis showed that WJ-MSC were positive for the typical MSC-specific markers CD44, CD73, CD90, and CD105 and negative for control markers CD14, CD19, CD34, CD45, and HLA-DR (Supplementary Fig. S1; Supplementary Data are available online at www.liebertpub.com/tea). They differentiated into adipocytes, osteoblasts, and chondrocytes under suitable conditions (Supplementary Fig. S2). These results demonstrated that WJ-MSCs used for this study had the MSC characteristics and were indeed adult stem cells.

Previous studies revealed that stem cell transdifferentiation was induced by suitable growth factors, cytokines, or transcription factors.^33,34 Hepatocyte growth factor (HGF) plays a critical role in the development and regeneration of liver cells, and fibroblast growth factor (FGF)-4 plays an important role in initial endoderm patterning and specification.^35,36 In addition, FGF can act during the initial stage of hepatic development, and HGF was involved in the later maturation stage.³⁷ In this study, HGF and FGF-4 were used for inducing WJ-MSCs into hepatocyte-like cells. WJ-MSCs expressed hepatocyte-specific markers ALB, AFP, and CK-18 after they were induced for 21 days in the hepatocyte differentiation medium (Supplementary Fig. S3A, B). AFP is a marker of early fetal hepatocyte differentiation, and ALB and CK-18 are markers of mature hepatocytes. These markers were commonly used to detect hepatocyte-like cells derived from stem cells.^14,38 This study also showed that differentiated cells were positive for periodic acid-Schiff staining and low-density lipoprotein (LDL) uptake assay (Supplementary Fig. S3C). Periodic acid–Schiff staining and LDL uptake assay are common hepatic functional assays to detect glycogen storage and LDL absorption respectively.^37,38 These results showed that WJ-MSCs used for this study could differentiate into hepatocyte-like cells in vitro and had the typical characteristics of hepatocytes, suggesting that they may also differentiate into hepatocytes in vivo after their transplantation.

In this study, CCl₄ was used to induce liver injury. It is commonly used for the study of liver diseases.³⁹ It causes liver damage by the formation of reactive intermediates in the endoplasmic reticulum through isoenzymes of cytochrome P-450. It also causes significant alterations to mitochondrial calcium homeostasis.⁴⁰ In this study, the concentrations of serum ALT, TB, and ALB were measured to determine the liver injury and recovery of hepatic functions. ALT plays an important role in amino acid metabolism and is a sensitive indicator of hepatocellular injury. Remarkable increase of ALT suggests acute hepatitis and hepatotoxicity. Hematin can be uptaken by hepatocytes and transformed by hepatocytes to bilirubin, which flows into bile and is excreted through bile duct. Liver injury increases bilirubin, which clinically is a routine test of liver functions. ALB is produced by hepatocytes and is another indicator of liver functions. Reduced concentration of ALB indicates the loss of functional liver cells. In this study, CCl₄ significantly increases serum ALT and TB and decreased serum ALB (Fig. 2B). HE staining and Masson staining also confirmed that the administration of CCl₄ induced liver injury (Fig. 2C).

Three-dimensional biodegradable scaffolds as supporting carriers for tissue regeneration may be used for hepatic tissue regeneration for engineering and the treatment of liver diseases.⁴¹ Three-dimensional scaffolds can provide a platform for cell attachment and differentiation and support specific tissue structures and shapes.⁴² Ideal scaffolds for liver tissue engineering should be biocompatible and biodegradable and also have some mechanical rigidity and flexibility. In addition, scaffolds should be able to mimic the liver extracellular matrix, which is important to support the differentiation of stem cells into hepatocytes.⁴³ As a new member of PHA family, PHBVHHx showed good biocompatibility with many different cells, including fibroblasts, osteoblasts, and WJ-MSCs.^10,20 PHBVHHx also has adjustable physical properties and can be an ideal biomaterial for liver tissue engineering. In this study, PHBVHHx scaffolds showed much higher cell attachment and viability than the commonly used polymers PLA, P3HB4HB, and PHBHHx (Fig. 1B, C). PHBVHHx scaffolds loaded with WJ-MSCs were transplanted into liver-injured mice to investigate their effects on the recovery of hepatic functions. Morphology of liver from the mouse after 30 days of transplantation of PHBVHHx scaffolds loaded with WJ-MSCs significantly improved and looked similar to the normal liver (Fig. 3A). PHBVHHx scaffolds loaded with WJ-MSCs significantly decreased ALT and TB and increased ALB (Fig. 3B). HE and Masson staining showed that PHBVHHx scaffolds loaded with WJ-MSCs also significantly improved hepatic tissue structure and decreased collagen fibers, and hepatic lesions were markedly ameliorated (Fig. 4A).

Previous studies showed that after mice were subjected to liver injury by BLD (Bile duct ligation) or administration of CCl₄, the liver injury increased the expression of the bile duct epithelial cell gene CK-19 in bile ducts.^44–46 In this study, real-time RT-PCR showed that the expression of CK-19 was detected at a low level in normal mouse liver (Control) and significantly increased on day 30 after CCl₄ injection (Fig. 4B), suggesting that increased bile duct epithelial cells may be a marker of CCl₄-induced liver injury. CK-19 expression was significantly lower in mouse liver on days 14 and 30 in the WJ-MSCs+scaffold group than in the CCl₄ group (Fig. 4B), suggesting that WJ-MSCs promoted the reconstruction of normal liver structures from injured liver. These results demonstrated that PHBVHHx scaffolds loaded with WJ-MSCs significantly promoted the recovery of injured liver.

There are many sites for scaffold transplantation, including omentum, small intestinal mesentery, and subcutaneous space of the abdominal wall.²⁶ Previous study demonstrated that the omentum is the most favorable bed for engraftment of hepatocyte–polymer tissue-engineered constructs compared with small intestinal mesentery and subcutaneous space of the abdominal wall.²⁶ The omentum is a fold of the peritoneum anchored to the stomach and transverse colon that drapes over the small intestine. The omentum is highly vascular and contains a relatively large surface area.²⁶ It has high rate of angiogenesis into cell-polymer constructs and is rich in hepatotrophic factors, and the surrounding tissue may influence the survival and proliferation of the transplanted hepatocytes by other unknown interactions.²⁶ So, the omentum is an ideal site for hepatocyte engraftment and was chosen as a transplantation site in this study. Many studies showed that after cells or scaffolds were implanted into different sites of animals, they promoted the regeneration of injured liver.^47–50 The paracrine effect of MSCs can help to restore liver functions. Previous studies showed that MSCs secreted some cytokines and growth factors, which were beneficial to the regeneration of injured liver.⁵¹ For example, HGF can promote hepatocyte proliferation and liver regeneration,⁵² and FGF-4 has critical functions in the initiation of mammalian liver development from endoderm.³⁶ In this study, after WJ-MSCs were transplanted within the omentum, WJ-MSCs and cells differentiated from them may also secrete some cytokines and growth factors, which may promote the regeneration of injured liver directly by diffusing into mouse liver, or indirectly by transportation into liver through blood vessels.

Injured liver can also release some growth factor and cytokines, which can induce MSCs to differentiate into hepatocyte-like cells.^53,54 Previous studies found that after MSCs were cocultured with injured liver or transplanted directly to liver-injured animals, they differentiated into hepatocyte-like cells.^55,56 In this study, WJ-MSCs in scaffolds differentiated into hepatocyte-like cells after their transplantation into liver-injured mice for 14 and 30 days (Fig. 5A–C).

CM-DiI is common fluorescent dye for cell tracking. Previous study showed that the fluorescence decreased over time in vitro after MSCs were labeled with CM-DiI and was still detectable after 5 weeks.²⁴ Fluorescence was detected in MSCs labeled with CM-DiI 6 weeks after injection into sheep skeletal muscle and 2 weeks after implantation of biomaterial scaffold containing MSCs.²⁴ In this study, PHBVHHx scaffolds loaded with WJ-MSCs labeled with CM-DiI were transplanted into liver-injured mice. The fluorescence also decreased over time and was still observed after 30 days of transplantation (Fig. 6A). This result is consistent with the previous observation.²⁴ Previous study showed that concentrations of ≥6 μM CM-DiI impaired cell division, and therefore, 4 μM concentration was chosen.²⁴ MSCs labeled with CM-DiI could be induced to differentiate into chondrocytes and cardiomyocytes.²⁴ In this study, WJ-MSCs were also labeled with 4 μM CM-DiI as previously described.²⁴

Conclusions

This study demonstrated that WJ-MSCs loaded into PHBVHHx scaffolds significantly improved the recovery of injured liver. The underlying mechanisms need to be investigated. This study supports that WJ-MSCs loaded into PHBVHHx scaffolds can be further tested for liver tissue engineering.

Footnotes

Acknowledgments

This work was supported by National Natural Science Foundation of China (grant no. 30870650 and grant no. 31171304 to X.W.), Research Foundation for Doctoral Discipline of Higher Education (grant no. 20114401110007 to X.W.), and the Fundamental Research Funds for the Central Universities (grant no. 21612107 to X.W.).

Disclosure Statement

No competing financial interests exist.

References

Arulraj

, and Neuberger

Liver transplantation: filling the gap between supply and demand. Clin Med, 11, 194, 2011.

Olson

J.L.

, Atala

, and Yoo

J.J.

Tissue engineering: current strategies and future directions. Chonnam Med J, 47, 1, 2011.

, Tao

, Wu

, Cao

, Xin

, Li

, et al. 3D PLGA scaffolds improve differentiation and function of bone marrow mesenchymal stem cell-derived hepatocytes. Stem Cells Dev, 19, 1427, 2010.

Lees

J.G.

, Lim

S.A.

, Croll

, Williams

, Lui

, Cooper-White

, et al. Transplantation of 3D scaffolds seeded with human embryonic stem cells: biological features of surrogate tissue and teratoma-forming potential. Regen Med, 2, 289, 2007.

Steinbuchel

Perspectives for biotechnological production and utilization of biopolymers: metabolic engineering of polyhydroxyalkanoate biosynthesis pathways as a successful example. Macromol Biosci, 1, 1, 2001.

Chen

G.Q.

, and Wu

The application of polyhydroxyalkanoates as tissue engineering materials. Biomaterials, 26, 6565, 2005.

Wróbel

, Zebrowski

, and Szopa

Polyhydroxybutyrate synthesis in transgenic flax. J Biotechnol, 107, 41, 2004.

X.H.

, Wu

, and Chen

G.Q.

In vitro study on hemocompatibility and cytocompatibility of poly (3-hydroxybutyrate-co-3-hydroxyhexanoate). J Biomater Sci Polym Ed, 17, 1107, 2006.

Luo

, Wei

, and Chen

G.Q.

Physical properties and biocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) blended with poly(3-hydroxybutyrate-co-4-hydroxybutyrate). J Biomater Sci Polym Ed, 20, 1537, 2009.

10.

Y.J.

, Wei

, Zhao

, Liu

Y.S.

, and Chen

G.Q.

Biocompatibility of poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) with bone marrow mesenchymal stem cells. Acta Biomater, 5, 1115, 2009.

11.

G.Z.

, Wei

, and Chen

G.Q.

Growth of human umbilical cord Wharton's Jelly-derived mesenchymal stem cells on the terpolyester poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate). J Biomater Sci Polym Ed, 20, 325, 2009.

12.

Zhao

, Ren

, Zhu

, and Han

Stem/progenitor cells in liver injury repair and regeneration. Biol Cell, 101, 557, 2009.

13.

Pittenger

M.F.

, Mackay

A.M.

, Beck

S.C.

, Jaiswal

R.K.

, Douglas

, Mosca

J.D.

, et al. Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143, 1999.

14.

, Zeng

Y.M.

, Wan

M.R.

, and Lu

X.F.

Induction of human bone marrow mesenchymal stem cells differentiation into neural-like cells using cerebrospinal fluid. Cell Biochem Biophys, 59, 179, 2011.

15.

Battiwalla

, and Hematti

Mesenchymal stem cells in hematopoietic stem cell transplantation. Cytotherapy, 11, 503, 2009.

16.

Maitra

, Szekely

, Gjini

, Laughlin

M.J.

, Dennis

, Haynesworth

S.E.

, et al. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant, 33, 597, 2004.

17.

L.F.

, Wang

N.N.

, Liu

Y.S.

, and Wei

Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A, 15, 2865, 2009.

18.

Aggarwal

, and Pittenger

M.F.

Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815, 2005.

19.

Y.S.

, Cheng

Y.C.

, Lin

M.Y.

, Cheng

, Chu

P.M.

, Chou

S.C.

, et al. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells, 24, 115, 2006.

20.

, Li

X.T.

, and Chen

G.Q.

Interactions between a poly(3-hydroxybutyrate-co-3-hydroxyvalerate-co-3-hydroxyhexanoate) terpolyester and human keratinocytes. Biomaterials, 29, 3807, 2008.

21.

You

, Peng

, Li

, Ma

, Wang

, Shu

, et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials, 32, 2305, 2011.

22.

Lee

Y.J.

, Ko

J.S.

, and Kim

H.M.

The role of cell signaling defects on the proliferation of osteoblasts on the calcium phosphate apatite thin film. Biomaterials, 27, 3738, 2006.

23.

Ghoddusi

, Tavakkol Afshari

, Donyavi

, Brook

, Disfani

, and Esmaeelzadeh

Cytotoxic effect of a new endodontic cement and mineral trioxide aggregate on L929 line culture. Iran Endod J, 3, 17, 2008.

24.

Weir

, Morel-Kopp

M.C.

, Gill

, Tinworth

, Ladd

, Hunyor

S.N.

, et al. Mesenchymal stem cells: isolation, characterisation and in vivo fluorescent dye tracking. Heart Lung Circ, 17, 395, 2008.

25.

Lin

, Lin

, Bo

, Weidong

, Chen

, and Xu

Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells in an alginate scaffold. Cell Prolif, 43, 427, 2010.

26.

Lee

, Cusick

R.A.

, Utsunomiya

, Ma

P.X.

, Langer

, and Vacanti

J.P.

Effect of implantation site on hepatocytes heterotopically transplanted on biodegradable polymer scaffolds. Tissue Eng, 9, 1227, 2003.

27.

Zhang

Y.N.

, Lie

P.C.

, and Wei

Differentiation of mesenchymal stromal cells derived from umbilical cord Wharton's jelly into hepatocyte-like cells. Cytotherapy, 11, 548, 2009.

28.

Wang

H.S.

, Hung

S.C.

, Peng

S.T.

, Huang

C.C.

, Wei

H.M.

, Guo

Y.J.

, et al. Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 22, 1330, 2004.

29.

Schwartz

R.E.

, Reyes

, Koodie

, Jiang

, Blackstad

, Lund

, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest, 109, 1291, 2002.

30.

, Teng

G.J.

, Lu

, Jin

, Zhang

, et al. In vivo differentiation of magnetically labeled mesenchymal stem cells into hepatocytes for cell therapy to repair damaged liver. Invest Radiol, 45, 625, 2010.

31.

Zhao

, Ren

, Li

, Chen

, Zhang

, Gong

, et al. Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Cytotherapy, 11, 414, 2009.

32.

Ghannam

, Bouffi

, Djouad

, Jorgensen

, and Noël

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Ther, 1, 2, 2010.

33.

Baksh

, Song

, and Tuan

R.S.

Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med, 8, 301, 2004.

34.

Darlington

G.J.

Molecular mechanisms of liver development and differentiation. Curr Opin Cell Biol, 11, 678, 1999.

35.

Michalopoulos

G.K.

, Bowen

W.C.

, Mulè

, and Luo

HGF-, EGF-, and dexamethasone-induced gene expression patterns during formation of tissue in hepatic organoid cultures. Gene Expr, 11, 55, 2003.

36.

Jung

, Zheng

, Goldfarb

, and Zaret

K.S.

Initiation of mammalian liver development from endoderm by fibroblast growth factors. Science, 284, 1998, 1999.

37.

Kim

, Kim

, Jung

, Kim

, and Han

Y.M.

Expression profiles of miRNAs in human embryonic stem cells during hepatocyte differentiation. Hepatol Res, 41, 170, 2011.

38.

Pournasr

, Mohamadnejad

, Bagheri

, Aghdami

, Shahsavani

, Malekzadeh

, et al. In vitro differentiation of human bone marrow mesenchymal stem cells into hepatocyte-like cells. Arch Iran Med, 14, 244, 2011.

39.

Wang

, Lafdil

, Wang

, Yin

, Feng

, and Gao

Tissue inhibitor of metalloproteinase 1 (TIMP-1) deficiency exacerbates carbon tetrachloride-induced liver injury and fibrosis in mice: involvement of hepatocyte STAT3 in TIMP-1 production. Cell Biosci, 1, 14, 2011.

40.

Tuñón

M.J.

, Alvarez

, Culebras

J.M.

, and González-Gallego

An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure. World J Gastroenterol, 15, 3086, 2009.

41.

Török

, Lutgehetmann

, Bierwolf

, Melbeck

, Düllmann

, Nashan

, et al. Primary human hepatocytes on biodegradable poly(l-lactic acid) matrices: a promising model for improving transplantation efficiency with tissue engineering. Liver Transpl, 17, 104, 2011.

42.

Uyama

, Kaufmann

P.M.

, Kneser

, Fiegel

H.C.

, Pollok

J.M.

, Kluth

, et al. Hepatocyte transplantation using biodegradable matrices in ascorbic acid-deficient rats: comparison with heterotopically transplanted liver grafts. Transplantation, 71, 1226, 2001.

43.

Hammond

J.S.

, Beckingham

I.J.

, and Shakesheff

K.M.

Scaffolds for liver tissue engineering. Expert Rev Med Devices, 3, 21, 2006.

44.

Sokolović

, Rodriguez-Ortigosa

C.M.

, Bloemendaal

L.T.

, Oude Elferink

R.P.

, Prieto

, and Bosma

P.J.

Insulin-like growth factor 1 enhances bile-duct proliferation and fibrosis in Abcb4(−/−) mice. Biochim Biophys Acta, 1832, 697, 2013.

45.

Wen

Y.A.

, Liu

, Zhou

Q.Y.

, Huang

S.F.

, Luo

, Xiang

, et al. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice. Exp Toxicol Pathol, 63, 277, 2011.

46.

Scholten

, Osterreicher

C.H.

, Scholten

, Iwaisako

, Gu

, Brenner

D.A.

, et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology, 139, 987, 2010.

47.

, Zhang

, You

, Li

, Liu

, Jiang

, et al. The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice. Biomaterials, 33, 8995, 2012.

48.

Piryaei

, Valojerdi

M.R.

, Shahsavani

, and Baharvand

Differentiation of bone marrow-derived mesenchymal stem cells into hepatocyte-like cells on nanofibers and their transplantation into a carbon tetrachloride-induced liver fibrosis model. Stem Cell Rev, 7, 103, 2011.

49.

Secchiero

, Corallini

, Zavan

, Tripodo

, Vindigni

, and Zauli

Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts. Invest New Drugs, 30, 803, 2012.

50.

Tai

B.C.

, Du

, Gao

, Wan

A.C.

, and Ying

J.Y.

The use of a polyelectrolyte fibrous scaffold to deliver differentiated hMSCs to the liver. Biomaterials, 31, 48, 2010.

51.

van Poll

, Parekkadan

, Cho

C.H.

, Berthiaume

, Nahmias

, Tilles

A.W.

, et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology, 47, 1634, 2008.

52.

Jin

S.Z.

, Meng

X.W.

, Sun

, Han

M.Z.

, Liu

B.R.

, Wang

X.H.

, et al. Hepatocyte growth factor promotes liver regeneration induced by transfusion of bone marrow mononuclear cells in a murine acute liver failure model. J Hepatobiliary Pancreat Sci, 18, 397, 2011.

53.

Yan

, Xu

, Qian

, Si

, Zhu

, Cao

, et al. Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int, 29, 356, 2009.

54.

Mohsin

, Shams

, Ali Nasir

, Khan

, Javaid Awan

, Khan

S.N.

, et al. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue. Differentiation, 81, 42, 2011.

55.

Luk

J.M.

, Wang

P.P.

, Lee

C.K.

, Wang

J.H.

, and Fan

S.T.

Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods, 305, 39, 2005.

56.

Dong

X.J.

, Zhang

, Pan

R.L.

, Xiang

L.X.

, and Shao

J.Z.

Identification of cytokines involved in hepatic differentiation of mBM-MSCs under liver-injury conditions. World J Gastroenterol, 16, 3267, 2010.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.51 MB

0.00 MB